Appendix OUnit costs

Publication Details

O.1. Risk factors and risk assessment tools

None.

O.2. Diagnostic tests

See Table 63 in Appendix N.

O.3. Severity risk tools

Table 91. Unit costs of severity risk tools.

Table 91

Unit costs of severity risk tools.

O.4. Surveillance for the early detection of hepatocellular carcinoma (HCC)

See Table 64 in Appendix N.

O.5. Surveillance for the detection of varices

See Table 64 in Appendix N.

O.6. Prophylaxis of variceal haemorrhage

Table 92. Unit costs of variceal haemorrhage prophylaxis – band ligation.

Table 92

Unit costs of variceal haemorrhage prophylaxis – band ligation.

Table 93. Unit costs of variceal haemorrhage prophylaxis – beta blockers.

Table 93

Unit costs of variceal haemorrhage prophylaxis – beta blockers.

O.7. Primary prevention of bacterial infections in cirrhosis and gastrointestinal bleeding

Table 94. Unit costs of antibiotics to treat bacterial infections.

Table 94

Unit costs of antibiotics to treat bacterial infections.

O.8. Transjugular intrahepatic portosystemic shunt (TIPS) versus large-volume paracentesis (LVP) for ascites

Table 95. Unit costs of TIPS and LVP procedures.

Table 95

Unit costs of TIPS and LVP procedures.

O.9. Primary prevention of spontaneous bacterial peritonitis (SBP) in people with cirrhosis and ascites

Table 96. Unit costs of antibiotics used for the primary prevention of SBP.

Table 96

Unit costs of antibiotics used for the primary prevention of SBP.

Table 97. Unit costs of managing SBP related complications.

Table 97

Unit costs of managing SBP related complications.

O.10. Volume replacers in hepatorenal syndrome

Table 98. Unit costs of IV volume replacers.

Table 98

Unit costs of IV volume replacers.

O.11. Management of an episode of acute hepatic encephalopathy

Table 99. Unit costs of drugs used to manage acute hepatic encephalopathy.

Table 99

Unit costs of drugs used to manage acute hepatic encephalopathy.